waouuu... this could be a major medical breakthrough...
Disclaimer
This marketing document has been issued by Bank Syz Ltd. It is not intended for distribution to, publication, provision or use by individuals or legal entities that are citizens of or reside in a state, country or jurisdiction in which applicable laws and regulations prohibit its distribution, publication, provision or use. It is not directed to any person or entity to whom it would be illegal to send such marketing material. This document is intended for informational purposes only and should not be construed as an offer, solicitation or recommendation for the subscription, purchase, sale or safekeeping of any security or financial instrument or for the engagement in any other transaction, as the provision of any investment advice or service, or as a contractual document. Nothing in this document constitutes an investment, legal, tax or accounting advice or a representation that any investment or strategy is suitable or appropriate for an investor's particular and individual circumstances, nor does it constitute a personalized investment advice for any investor. This document reflects the information, opinions and comments of Bank Syz Ltd. as of the date of its publication, which are subject to change without notice. The opinions and comments of the authors in this document reflect their current views and may not coincide with those of other Syz Group entities or third parties, which may have reached different conclusions. The market valuations, terms and calculations contained herein are estimates only. The information provided comes from sources deemed reliable, but Bank Syz Ltd. does not guarantee its completeness, accuracy, reliability and actuality. Past performance gives no indication of nor guarantees current or future results. Bank Syz Ltd. accepts no liability for any loss arising from the use of this document.
Related Articles
Chinese IPOs in America have collapsed 93% since 2021, raising just $875 million this year vs. $13 billion at the peak. Meanwhile, Hong Kong is reaping the rewards — Chinese listings there surged 164% to $18.4 billion across 56 deals. The turning point came after Beijing’s regulatory crackdown on Didi’s 2021 New York debut — a short-lived listing that ended with a forced delisting. Since then, companies in “strategic industries” face a regulatory maze for U.S. approval. The Nasdaq has raised the bar with a $25 million minimum for Chinese IPOs, while Hong Kong introduced its “Technology Enterprises Channel” to fast-track tech listings. source : cnbc
Takaichi garnered 237 votes in the first round of voting, negating the need for a runoff vote in the 465-seat Lower House, according to public broadcaster NHK. Her victory comes after the ruling Liberal Democratic Party allied with the Japan Innovation Party and reportedly signed an agreement over the weekend to form a coalition government. Takaichi agreed to back JIP policies such as a reduction in parliamentary seats, free high school education and a two-year pause on food consumption tax, according to Reuters. Source: CNBC
Interesting colour from Bloomberg on gold demand in Japan at present... Source: Bloomberg, Krishan Gopaul on X

